Gutierrez-Carretero, E.; Mayoral-González, I.; Jesús Morón, F.; Fernández-Quero, M.; DomÃnguez-RodrÃguez, A.; Ordóñez, A.; Smani, T.
miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis. Biomedicines 2021, 9, 354.
https://doi.org/10.3390/biomedicines9040354
AMA Style
Gutierrez-Carretero E, Mayoral-González I, Jesús Morón F, Fernández-Quero M, DomÃnguez-RodrÃguez A, Ordóñez A, Smani T.
miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis. Biomedicines. 2021; 9(4):354.
https://doi.org/10.3390/biomedicines9040354
Chicago/Turabian Style
Gutierrez-Carretero, Encarnación, Isabel Mayoral-González, Francisco Jesús Morón, Mónica Fernández-Quero, Alejandro DomÃnguez-RodrÃguez, Antonio Ordóñez, and Tarik Smani.
2021. "miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis" Biomedicines 9, no. 4: 354.
https://doi.org/10.3390/biomedicines9040354
APA Style
Gutierrez-Carretero, E., Mayoral-González, I., Jesús Morón, F., Fernández-Quero, M., DomÃnguez-RodrÃguez, A., Ordóñez, A., & Smani, T.
(2021). miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis. Biomedicines, 9(4), 354.
https://doi.org/10.3390/biomedicines9040354